Key result
Emergent pericardiocentesis and induction therapy with cytarabine and daunorubicin resulted in no residual AML at 14 days in a 34-year-old male presenting with cardiac tamponade.
Case Report (n=1)
Cardiac tamponade can be a rare initial presentation of acute myeloid leukemia, requiring prompt pericardiocentesis and systemic therapy.
May support combined pericardiocentesis and induction chemotherapy in rare AML tamponade; hypothesis-generating and requires prospective validation.
Acute myeloid leukemia (AML) is a complex disease with a variety of presentations. A large pericardial effusion is rare, occurring in less than 0.5% of all patients with AML prior to treatment. A 34-year-old male presented with dyspnea, malaise, and weight loss. On physical exam, he was noted to be hypoxic, tachypneic, tachycardic, and hypotensive. He had cervical lymphadenopathy and jugular venous distention. His WBC count was 110 bil/L with 33% blasts. Bone marrow biopsy confirmed AML with 60% blasts. Leukemic cells were also seen in the cerebrospinal fluid on lumbar puncture. An echocardiogram revealed a large pericardial effusion causing tamponade. He underwent emergent pericardiocentesis, and malignant cells were present in the pericardial fluid. Induction therapy with standard dose cytarabine and daunorubicin was initiated, and bone marrow biopsy 14 days later showed no residual AML. This case demonstrates the importance of a thorough evaluation of each organ system when caring for a patient with AML.
No takes yet. Share an insight, caveat, or question.
Karmo et al. (2018) conducted a case report in Acute Myeloid Leukemia with Cardiac Tamponade (n=1). Pericardiocentesis and induction therapy (cytarabine and daunorubicin) was evaluated. Emergent pericardiocentesis and induction therapy with cytarabine and daunorubicin resulted in no residual AML at 14 days in a 34-year-old male presenting with cardiac tamponade.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: